Genelux (GNLX) EBIT (2022 - 2026)
Genelux (GNLX) recorded quarterly EBIT of -$9.2 million in Q1 2026, up 2.56% quarter-over-quarter from -$9.4 million in Q4 2025, and down 17.34% on a YoY basis from -$11.1 million in Q1 2025.
Genelux (GNLX) EBIT (2022 - 2026) Analysis & Trends
Genelux's EBIT history runs 5 years deep, the most recent figure standing at -$9.2 million for Q1 2026.
- In Q1 2026, EBIT fell 17.34% year-over-year to -$9.2 million; the TTM figure through Mar 2026 stood at -$34.6 million (down 10.1% YoY), while the FY2025 annual figure was -$33.2 million, down 4.79% from the prior year.
- EBIT was -$9.2 million for Q1 2026 at Genelux, up from -$9.4 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $6.3 million in Q3 2022 to a low of -$9.7 million in Q4 2024.
- Historically, EBIT has averaged -$6.3 million across 5 years, with a median of -$7.0 million in 2023.
- The sharpest annual moves came in 2023 and 2025: EBIT slumped 183.65% in 2023, then advanced 3.68% in 2025.
- A 5-year view of EBIT shows it stood at -$3.1 million in 2022, then plunged by 126.28% to -$7.0 million in 2023, then sank by 39.24% to -$9.7 million in 2024, then grew by 3.45% to -$9.4 million in 2025, then climbed by 2.56% to -$9.2 million in 2026.
- The last three EBIT figures came in at -$9.2 million (Q1 2026), -$9.4 million (Q4 2025), and -$8.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | -9.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.17 Mn |
| Dec 31, 2025 | -9.41 Mn |
| Sep 30, 2025 | -8.19 Mn |
| Jun 30, 2025 | -7.79 Mn |
| Mar 31, 2025 | -7.82 Mn |
| Dec 31, 2024 | -9.75 Mn |
| Sep 30, 2024 | -6.94 Mn |
| Jun 30, 2024 | -6.89 Mn |
| Mar 31, 2024 | -8.12 Mn |
| Dec 31, 2023 | -7.00 Mn |
| Sep 30, 2023 | -5.31 Mn |
| Jun 30, 2023 | -5.40 Mn |
| Mar 31, 2023 | -6.46 Mn |
| Dec 31, 2022 | -3.09 Mn |
| Sep 30, 2022 | 6.34 Mn |